** Shares of biotech co Ginkgo Bioworks DNA.N fall 4% to $9.9
** Co late on Tuesday forecast 2025 revenue to be $160 mln to $180 mln, lower than analyst estimates of $189 mln as per data compiled by LSEG
** DNA reported Q4 net loss of $107.5 mln, vs analyst estimates of $80.1 mln
** Co reported Q4 revenue of $44 mln, vs analyst estimates of $44.5 mln
** Stock has fallen 82.4% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.